NOD1 is a key mediator of atrial myopathy in heart failure

Theranostics · Published 2026-06-04 · DOI 10.7150/thno.134756

Free full text

Authors (32)

Marta Gil-Fernández, Almudena Val-Blasco, Andrea Bueno-Sen, Paula Cantolla-Pablo, Carlos Galán-Arriola, Ali Ayaon, Teresa López-Fernández, Yuriana Aguilar-Sanchez, Satadru K Lahiri, José Alberto Navarro-García, Rafael Peinado, Angel Aroca, Miguel Ángel Rubio, José Antonio Blázquez, María Tamayo, Eduardo López-Collazo, Gema Ruiz-Hurtado, Inmaculada Jorge, Jesús Vázquez, Patricia Prieto, Tarik Smani, Antonio Ordoñez, David Filgueiras-Dama, Raúl Moreno, Borja Rivero-Santana, Jorge Nuche, José Jalife, Borja Ibáñez, Carmen Delgado, Lisardo Boscá, Xander H.T. Wehrens, María Fernández-Velasco

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gil-Fernández, M., Val-Blasco, A., Bueno-Sen, A., et al. (2026). NOD1 is a key mediator of atrial myopathy in heart failure. Theranostics. https://doi.org/10.7150/thno.134756

Related articles

• Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment · Theranostics · 2026 · Same journal
• Surface-cleaned black phosphorus nanosheets chelate iron and rebalance the ferroptosis-immune axis in acute kidney injury · Theranostics · 2026 · Same journal
• Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways · Theranostics · 2026 · Same journal
• Inhibition of SRC prevents bone metastasis of breast cancer by blocking metastatic cell motility and bone directionality · Theranostics · 2026 · Same journal
• Magnetic hyperthermia as an intracellular immunomodulatory technology: From heat transduction to tumor immune reprogramming · Theranostics · 2026 · Same journal
• Ultra-high-field magnetic resonance imaging reveals sex-specific recovery after ischemic stroke following treatment with three-dimensional human mesenchymal stem cell–derived extracellular vesicles · Theranostics · 2026 · Same journal
• Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications · Theranostics · 2026 · Same journal
• Targeting microglial MyD88 reprograms injury-activated microglia and promotes spinal cord repair via TGF-β signaling and biomimetic nanodelivery · Theranostics · 2026 · Same journal
• miR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects · Theranostics · 2026 · Same journal
• Recent advances in targeting cyanine dyes: hierarchical targeting mechanisms and theranostic integration for multi-disease precision therapy · Theranostics · 2026 · Same journal